They also described a subset of patients with homozygous R1060W genotype who had a higher residual ADAMTS13 activity and later age at onset of first TTP episode requiring therapeutic intervention. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.